Venture capital and co-development partners are raising expectations prior to committing funding, and with many virtual and emerging pharma companies depending on a single lead candidate for success, it is more important than ever to make that candidate as attractive as possible. The risk to small companies of putting all their eggs in one basket can be high considering limitations on resources, funding, and broad expertise needed to advance candidates through clinical trials. What strategies can be used to help these companies succeed in both advancing their candidates and attracting investors?

Attendees will hear from an industry expert on reliable approaches that have supported hundreds of small and virtual companies help build value to their lead candidates in early phases of development as well as help accelerate the development process to overcome formulation challenges.

Featured Speaker

Bryan Knox

Bryan Knox

General Manager
Catalent

Bryan is a pharmaceutical development executive and accomplished scientist with over 20 years of experience in drug delivery, product development, and operations. Bryan’s primary expertise is in accelerating development programs and developing technology enabled products in the early phases of development. He has worked on hundreds of development projects and helped virtual, emerging and large pharmaceutical customers advance their candidates from preclinical candidate selection to the market, helping to overcome issues and add value to the product. Bryan earned his MBA from The University of California, San Diego’s Rady School of Management and his Bachelor of Science in Biochemistry from The University of California, San Diego.

NOW AVAILABLE ON-DEMAND

Register to watch now